Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 1 hour ago
Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
about 1 hour ago
Boehringer is banking on the program offering a new oral and precision...
Accent halts solid tumor trial over adverse events, pivots to other lead cancer program
about 3 hours ago
Accent Therapeutics has halted work on a solid tumor drug due to...
Asahi Kasei scoops up Germany's Aicuris for $920M in R&D portfolio boost
about 6 hours ago
Japanese conglomerate Asahi Kasei is acquiring Aicuris in a $920 million deal...
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
about 18 hours ago
After promising to sell off 7% of its business back in November...
Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
about 19 hours ago
In an effort to battle against what members feel is an existential...
ARPA-H designates up to $144M for anti-aging medical research
about 20 hours ago
The federal government is pledging as much as $144 million to anti-aging...
After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
about 23 hours ago
After dumping its sole remaining gene therapy asset last year, Pfizer has...
Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
1 day ago
Following the launch of its Wegovy (semaglutide) pill at the beginning of...
GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug
1 day ago
Like Merck & Co.’s PAH drug Winrevair—which brought in $1.4 billion last...
Werewolf weighs sale or merger as cash reserves whimper
1 day ago
With its cash cache set to run out by the fourth quarter...
After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst
1 day ago
The average upfront value for a licensing deal between a Western biotech...
Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal
1 day ago
Harbour BioMed is setting sail as the Solstice begins, riding the waves...